# Stempoint Capital LP 13F holdings Q2 2026: $581 million

Checked November 20, 2026.

Stempoint Capital LP reported $581 million in 13F securities across 84 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Tango Therapeutics Inc at $38.2 million, 6.6% of the reported value. Since Q1 2026 it opened 34 new positions and exited 32.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $580,521,914
- Positions: 84
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1952142
- Form 13F file number: 028-23724
- CRD number: 324248
- Business address: 520 Madison Avenue 19th Floor, New York, NY 10022
- SEC filing: [0001420506-26-001687](https://www.sec.gov/Archives/edgar/data/1952142/000142050626001687/0001420506-26-001687-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/stempoint-capital-lp-324248)

## Top 25 holdings by value

The largest of 84 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 1,223,019 | $38.2 million | +821,181 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 283,657 | $37.8 million | -343,925 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 159,943 | $30 million | -403,321 |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 1,565,913 | $28.7 million | +1,086,191 |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 632,754 | $20.2 million | +246,400 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 200,851 | $19.6 million | +29,847 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 346,914 | $17.6 million | -379,962 |
| [Mineralys Therapeutics Inc](https://specstream.ai/data/institutional-holders/mineralys-therapeutics-inc-603170101) | COM | 602,686 | $16.3 million | -464,070 |
| [Biohaven LTD](https://specstream.ai/data/institutional-holders/biohaven-ltd-g1110e107) | COM | 1,064,200 | $15.8 million | -2,124,782 |
| [Surrozen Inc](https://specstream.ai/data/institutional-holders/surrozen-inc-86889p208) | COM NEW | 602,798 | $13.8 million | -118,822 |
| [Kiniksa Pharmaceuticals Intl](https://specstream.ai/data/institutional-holders/kiniksa-pharmaceuticals-intl-g52694109) | ORD SHS CL A | 209,234 | $13.4 million | New |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 239,146 | $13.2 million | -1,831,846 |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 248,015 | $13 million | +87,031 |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 622,723 | $12.5 million | New |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 37,243 | $12.5 million | -75,291 |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 348,408 | $12.3 million | -423,192 |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 464,171 | $11.4 million | -213,137 |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 159,349 | $11.3 million | -251,895 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 116,461 | $11.1 million | New |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 276,527 | $10.7 million | -1,216,461 |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 98,203 | $10.3 million | -21,921 |
| [Relmada Therapeutics Inc](https://specstream.ai/data/institutional-holders/relmada-therapeutics-inc-75955j402) | COM | 1,460,093 | $10.1 million | +265,275 |
| [Climb Bio Inc](https://specstream.ai/data/institutional-holders/climb-bio-inc-28658r106) | COM | 742,745 | $9.7 million | New |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 106,926 | $9.5 million | -228,286 |
| [Zura Bio LTD](https://specstream.ai/data/institutional-holders/zura-bio-ltd-g9ty5a101) | CLASS A ORD SHS | 1,368,215 | $8.1 million | -138,825 |

## New positions in Q2 2026

34 positions not in the filing for the quarter ended March 31, 2026. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Kiniksa Pharmaceuticals Intl](https://specstream.ai/data/institutional-holders/kiniksa-pharmaceuticals-intl-g52694109) | ORD SHS CL A | 209,234 | $13.4 million |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 622,723 | $12.5 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 116,461 | $11.1 million |
| [Climb Bio Inc](https://specstream.ai/data/institutional-holders/climb-bio-inc-28658r106) | COM | 742,745 | $9.7 million |
| [Inflarx NV](https://specstream.ai/data/institutional-holders/inflarx-nv-n44821101) | COM | 3,228,255 | $7.2 million |
| [Ovid Therapeutics Inc](https://specstream.ai/data/institutional-holders/ovid-therapeutics-inc-690469101) | COM | 2,417,283 | $6.5 million |
| [Equillium Inc](https://specstream.ai/data/institutional-holders/equillium-inc-29446k106) | COM | 2,016,607 | $6.5 million |
| [Damora Therapeutics Inc](https://specstream.ai/data/institutional-holders/damora-therapeutics-inc-36322q206) | COM NEW | 216,194 | $5.6 million |
| [Inventiva SA](https://specstream.ai/data/institutional-holders/inventiva-sa-46124u107) | ADS | 1,426,320 | $5.4 million |
| [Century Therapeutics Inc](https://specstream.ai/data/institutional-holders/century-therapeutics-inc-15673t100) | COM | 2,146,182 | $5.3 million |
| [Aura Biosciences Inc](https://specstream.ai/data/institutional-holders/aura-biosciences-inc-05153u107) | COM | 714,280 | $5.1 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 284,769 | $4 million |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 118,000 | $3.9 million |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 15,375 | $3.8 million |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 153,544 | $3.7 million |
| [Personalis Inc](https://specstream.ai/data/institutional-holders/personalis-inc-71535d106) | COM | 247,783 | $3.3 million |
| [Crescent Biopharma Inc.](https://specstream.ai/data/institutional-holders/crescent-biopharma-inc-g2545c104) | COM | 182,382 | $3.3 million |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 39,198 | $3.2 million |
| [Kodiak Sciences Inc](https://specstream.ai/data/institutional-holders/kodiak-sciences-inc-50015m109) | COM | 75,872 | $3 million |
| [Monopar Therapeutics Inc](https://specstream.ai/data/institutional-holders/monopar-therapeutics-inc-61023l207) | COM NEW | 30,125 | $2.8 million |
| [Rapport Therapeutics Inc](https://specstream.ai/data/institutional-holders/rapport-therapeutics-inc-75383l102) | COM | 66,582 | $2.8 million |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 66,995 | $2.1 million |
| [Calcimedica Inc](https://specstream.ai/data/institutional-holders/calcimedica-inc-38942q202) | COM NEW | 1,244,864 | $1.2 million |
| [Cellectar Biosciences Inc](https://specstream.ai/data/institutional-holders/cellectar-biosciences-inc-15117f880) | COM NEW | 354,938 | $986,728 |
| Personalis Inc | COM (call) | 470,000 | $810,750 |

## Positions exited in Q2 2026

32 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 2,431,486 | $56.8 million |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 998,938 | $29.8 million |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 1,012,150 | $18.4 million |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 581,728 | $18.3 million |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 853,122 | $16.4 million |
| [Nurix Therapeutics Inc](https://specstream.ai/data/institutional-holders/nurix-therapeutics-inc-67080m103) | COM | 630,452 | $9.8 million |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 387,554 | $8.8 million |
| [Faeth Therapeutics Inc](https://specstream.ai/data/institutional-holders/faeth-therapeutics-inc-81728a207) | COM NEW | 265,746 | $8.4 million |
| [Johnson & Johnson](https://specstream.ai/data/institutional-holders/johnson-johnson-478160104) | COM | 30,830 | $7.5 million |
| [X4 Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/x4-pharmaceuticals-inc-98420x202) | COM NEW | 1,701,484 | $7 million |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 118,122 | $6.9 million |
| [Invivyd Inc](https://specstream.ai/data/institutional-holders/invivyd-inc-00534a102) | COM | 3,749,092 | $4.9 million |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 308,068 | $4.3 million |
| [Twist Bioscience Corp](https://specstream.ai/data/institutional-holders/twist-bioscience-corp-90184d100) | COM | 86,220 | $4.1 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 269,484 | $4 million |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 52,770 | $4 million |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 127,086 | $3.8 million |
| [Forte Biosciences Inc](https://specstream.ai/data/institutional-holders/forte-biosciences-inc-34962g208) | COM NEW | 116,040 | $3 million |
| [Lipocine Inc New](https://specstream.ai/data/institutional-holders/lipocine-inc-new-53630x203) | COM NEW | 320,840 | $2.6 million |
| [Edwards Lifesciences Corp](https://specstream.ai/data/institutional-holders/edwards-lifesciences-corp-28176e108) | COM | 29,176 | $2.3 million |
| [Capricor Therapeutics Inc](https://specstream.ai/data/institutional-holders/capricor-therapeutics-inc-14070b309) | COM NEW | 75,184 | $2.3 million |
| Scholar Rock HLDG Corp | COM (call) | 200,000 | $1.2 million |
| [Sutro Biopharma Inc](https://specstream.ai/data/institutional-holders/sutro-biopharma-inc-869367201) | COM SHS | 46,590 | $1.2 million |
| Tyra Biosciences Inc | COM (call) | 200,000 | $580,000 |
| Immunovant Inc | COM (call) | 200,000 | $510,000 |

## Also on SpecStream

- [Stempoint Capital LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1952142/000142050626001687/0001420506-26-001687-index.htm)
- [Stempoint Capital LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/stempoint-capital-lp-324248)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Bar and grill restaurants in New York, New York](https://specstream.ai/data/businesses/bar-and-grill-restaurants/new-york-new-york-united-states)
- [Fabric wholesalers in New York, New York](https://specstream.ai/data/businesses/fabric-wholesalers/new-york-new-york-united-states)
- [Occupational therapy clinics in New York, New York](https://specstream.ai/data/businesses/occupational-therapy-clinics/new-york-new-york-united-states)
- [Turkish restaurants in New York, New York](https://specstream.ai/data/businesses/turkish-restaurants/new-york-new-york-united-states)
- [Cosmetic surgery practices in New York, New York](https://specstream.ai/data/businesses/cosmetic-surgery-practices/new-york-new-york-united-states)
- [Italian restaurants in New York, New York](https://specstream.ai/data/businesses/italian-restaurants/new-york-new-york-united-states)
